Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
TV-46000, A Long-Acting Subcutaneous Antipsychotic Agent, Demonstrated Improved Patient-Centered Outcomes in Patients with Schizophrenia.
Neuropsychiatr Dis Treat. 2024 Oct 9;20:1901-1917. doi: 10.2147/NDT.S459104. eCollection 2024.
Neuropsychiatr Dis Treat. 2024.
PMID: 39399879
Free PMC article.
A Long-Term Safety and Tolerability Study of TV-46000 for Subcutaneous Use in Patients with Schizophrenia: A Phase 3, Randomized, Double-Blinded Clinical Trial.
Kane JM, Eshet R, Harary E, Tohami O, Elgart A, Knebel H, Sharon N, Suett M, Franzenburg KR, Davis GL 3rd, Correll CU.
Kane JM, et al. Among authors: tohami o.
CNS Drugs. 2024 Aug;38(8):625-636. doi: 10.1007/s40263-024-01102-2. Epub 2024 Jul 2.
CNS Drugs. 2024.
PMID: 38954317
Free PMC article.
Clinical Trial.
Item in Clipboard
Efficacy and safety of TV-46000, a long-acting, subcutaneous, injectable formulation of risperidone, for schizophrenia: a randomised clinical trial in the USA and Bulgaria.
Kane JM, Harary E, Eshet R, Tohami O, Weiser M, Leucht S, Merenlender-Wagner A, Sharon N, Davis GL 3rd, Suett M, Franzenburg KR, Correll CU.
Kane JM, et al. Among authors: tohami o.
Lancet Psychiatry. 2023 Dec;10(12):934-943. doi: 10.1016/S2215-0366(23)00288-2. Epub 2023 Nov 2.
Lancet Psychiatry. 2023.
PMID: 37924833
Clinical Trial.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.